Market revenue in 2023 | USD 4.8 million |
Market revenue in 2030 | USD 13.0 million |
Growth rate | 15.2% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Italy 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
The rising adoption of advanced technologies is creating opportunities for growth in Italy 3D printed drugs market. Moreover, the growing geriatric population in the country is expected to fuel the market growth. For instance, as of January 2022, approximately 24% of the total population is aged 65 and above, and this percentage is projected to increase to 30% by 2040.
In the European Union (EU), this percentage is currently averaging 21%, with Italy having the highest share, followed by Finland, Greece, and Portugal. Meanwhile, Luxembourg and Ireland have the lowest shares at 15%. Furthermore, Italy's market growth is supported by new-age start-ups in the medical technology (medtech) ecosystem.
For instance, in April 2020, a group of researchers from Greece and Italy created a 3D printing technology to customize the drug delivery release rate for individual patients. Researchers actively relied on semi-solid extrusion 3D printing technology to achieve customized release of drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Italy 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account